...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Scoliosis >Factors influencing adherence to an app-based exercise program in adolescents with painful hyperkyphosis
【24h】

Factors influencing adherence to an app-based exercise program in adolescents with painful hyperkyphosis

机译：影响患有疼痛性后凸畸形的青少年坚持基于应用程序的运动计划的因素

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Software applications (apps) could potentially promote exercise adherence. However, it is unclear whether adolescents with painful hyperkyphosis will use an app designed for a home exercise program. The purpose of this study is to assess factors regarding adherence to an app-based home exercise program in adolescents with hyperkyphosis and back pain who were provided a one-time exercise treatment. Twenty-one participants were instructed in a one-time exercise treatment and asked to complete a home exercise program 3 times a week for 6?months using an app called PT PAL. At a 6-month follow-up, 14 participants completed a survey assessing factors related to their experiences using the app and their treatment engagement. Although most participants did not use the app, they reported performing their exercises a few times per week. The adolescent participants considered the app to be more of a barrier than a supportive measure for promoting exercise adherence. Most participants still reported bothersome back pain. Although adherence to the 6-month app-based home exercise program was not successful, adolescents still viewed technology support such as text reminders as a potential solution. ClinicalTrials.gov Identifier: NCT03212664 . Registered 11 July 2017. Retrospectively registered.
机译：软件应用程序（应用程序）可能会促进锻炼的依从性。但是，尚不清楚患有疼痛性后凸畸形的青少年是否会使用专为家庭锻炼计划设计的应用程序。这项研究的目的是评估在接受一次性运动治疗的患有过度驼背和背部疼痛的青少年中遵守基于应用程序的家庭锻炼计划的因素。 21名参与者接受了一次性运动治疗的指导，并被要求使用名为PT PAL的应用程序每周6次，每周3次完成一项家庭锻炼计划。在为期6个月的随访中，有14位参与者完成了一项调查，评估了与他们使用该应用程序的经历及其治疗参与有关的因素。尽管大多数参与者没有使用该应用程序，但他们报告每周进行几次锻炼。青春期的参与者认为，与促进运动坚持的支持措施相比，该应用程序更多地是障碍。大多数参与者仍然报告烦恼的背部疼痛。尽管坚持为期6个月的基于应用程序的家庭锻炼计划并不成功，但青少年仍将诸如文本提醒之类的技术支持视为一种潜在的解决方案。 ClinicalTrials.gov标识符：NCT03212664。 2017年7月11日注册。追溯注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号